Thomas A. Fitzgerald SEC EDGAR Filings (CIK 0001854168)

SEC EDGAR filings, ownership reports, and insider transactions for Thomas A. Fitzgerald.

Business address
C/O Transcode Therapeutics, Inc., 6 Liberty Square, #2382, Boston, MA, 02109
Top holdings (ownership)
RNAZ
Get insider transactions for this reporting owner
Thomas A. Fitzgerald has filed 9 SEC EDGAR filings since 08 Jul 2021

Latest Filings

Recent SEC filings for Thomas A. Fitzgerald including SC 13D, 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 21 Jun 2024
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 18 Jun 2024 14 Jun 2024 001-40363
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 02 Oct 2023 28 Sep 2023 001-40363
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 19 May 2023 19 May 2023 001-40363
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 14 Dec 2022 12 Dec 2022 001-40363
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 17 Jun 2022 16 Jun 2022 001-40363
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 02 Mar 2022 01 Mar 2022 001-40363
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 03 Feb 2022 01 Feb 2022 001-40363
3 Open 3 document View SEC filing for 3 FORM 3 08 Jul 2021 08 Jul 2021 001-40363

About this filer

Thomas A. Fitzgerald files with the SEC under CIK 0001854168. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages